Six-year longitudinal course and outcomes of subtypes of depression

British Journal of Psychiatry

Volumn 208, Issue 1, 2016, Pages 62-68

  Lamers, F ^a   Beekman, A T F ^a   Van Hemert, A M ^b   Schoevers, R A ^c   Penninx, B W J H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANXIETY DISORDER; ARTICLE; BODY MASS; CONTROLLED STUDY; DEPRESSION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MELANCHOLIA; METABOLIC SYNDROME X; OUTCOME ASSESSMENT; PREVALENCE; PSYCHIATRIC DIAGNOSIS; SUICIDAL IDEATION; THINKING; ANXIETY; CLASSIFICATION; DEPRESSIVE DISORDER, MAJOR; MIDDLE AGED; NETHERLANDS; PSYCHOLOGICAL RATING SCALE; SEVERITY OF ILLNESS INDEX;

ADULT; ANXIETY; BODY MASS INDEX; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NETHERLANDS; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; SUICIDAL IDEATION;

EID: 84956661995     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.114.153098     Document Type: Article

References (54)

1. Antonijevic IA. Depressive disorders-is it time to endorse different pathophysiologies? Psychoneuroendocrinology 2006; 31: 1-15.
2. Baumeister H, Parker G. Meta-review of depressive subtyping models. J Affect Disord 2012; 139: 126-40.
3. Penninx BW, Milaneschi Y, Lamers F, Vogelzangs N. Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Med 2013; 11: 129.
4. Lamers F, Vogelzangs N, Merikangas KR, de Jonge P, Beekman AT, Penninx BW. Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression. Mol Psychiatry 2013; 18: 692-9.
5. Kendler KS, Eaves LJ, Walters EE, Neale MC, Heath AC, Kessler RC. The identification and validation of distinct depressive syndromes in a population based sample of female twins. Arch Gen Psychiatry 1996; 53: 391-9.
6. Levitan RD, Davis C, Kaplan AS, Arenovich T, Phillips DI, Ravindran AV. Obesity comorbidity in unipolar major depressive disorder: Refining the core phenotype. J Clin Psychiatry 2012; 73: 1119-24.
7. Cizza G, Ronsaville DS, Kleitz H, Eskandari F, Mistry S, Torvik S, et al. Clinical subtypes of depression are associated with specific metabolic parameters and circadian endocrine profiles in women: The Power Study. PLoS One 2012; 7: E28912.
8. Kaestner F, Hettich M, Peters M, Sibrowski W, Hetzel G, Ponath G, et al. Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity. J Affect Disord 2005; 87: 305-11.
9. Hickman RJ, Khambaty T, Stewart JC. C-reactive protein is elevated in atypical but not nona typical depression: Data from the National Health and Nutrition Examination Survey (NHANES) 1999-2004. J Behav Med 2014; 37: 621-9.
10. Rothermundt M, Arolt V, Peters M, Gutbrodt H, Fenker J, Kersting A, et al. Inflammatory markers in major depression and melancholia. J Affect Disord 2001; 63: 93-102.
11. Anisman H, Ravindran AV, Griffiths J, Merali Z. Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features. Mol Psychiatry 1999; 4: 182-8.
12. Huang TL, Lee CT. T-helper 1/T-helper 2 cytokine imbalance and clinical phenotypes of acute-phase major depression. Psychiatry Clin Neurosci 2007; 61: 415-20.
13. Karlovic D, Serretti A, Vrkic N, Martinac M, Marcinko D. Serum concentrations of CRP, IL-6, TNF-alpha and cortisol in major depressive disorder with melancholic or atypical features. Psychiatry Res 2012; 198: 74-80.
14. Yoon HK, Kim YK, Lee HJ, Kwon DY, Kim L. Role of cytokines in atypical depression. Nord J Psychiatry 2012; 66: 183-8.
15. Dunjic-Kostic B, Ivkovic M, Radonjic NV, Petronijevic ND, Pantovic M, Damjanovic A, et al. Melancholic and atypical major depression-connection between cytokines, psychopathology and treatment. Prog Neuropsychopharmacol Biol Psychiatry 2013; 43: 1-6.
16. Stetler C, Miller GE. Depression and hypothalamic-pituitary-adrenal activation: A quantitative summary of four decades of research. Psychosom Med 2011; 73: 114-26.
17. Lam RW, Stewart JN. The validity of atypical depression in DSM-IV. Compr Psychiatry 1996; 37: 375-83.
18. Stewart JW, McGrath PJ, Quitkin FM, Klein DF. DSM-IV depression with atypical features: is it valid? Neuropsychopharmacology 2009; 34: 2625-32.
19. Kendler KS. The diagnostic validity of melancholic major depression in a population-based sample of female twins. Arch Gen Psychiatry 1997; 54: 299-304.
20. Sun N, Li Y, Cai Y, Chen J, Shen Y, Sun J, et al. A comparison of melancholic and nonmelancholic recurrent major depression in Han Chinese women. Depress Anxiety 2012; 29: 4-9.
21. Gili M, Roca M, Armengol S, Asensio D, Garcia-Campayo J, Parker G. Clinical patterns and treatment outcome in patients with melancholic, atypical and non-melancholic depressions. PLoS One 2012; 7: E48200.
22. Khan AY, Carrithers J, Preskorn SH, Lear R, Wisniewski SR, Rush JA, et al. Clinical and demographic factors associated with DSM-IV melancholic depression. Ann Clin Psychiatry 2006; 18: 91-8.
23. Angst J, Gamma A, Sellaro R, Zhang H, Merikangas K. Toward validation of atypical depression in the community: Results of the Zurich cohort study. J Affect Disord 2002; 72: 125-38.
24. Sachs-Ericsson N, Selby E, Corsentino E, Collins N, Sawyer K, Hames J, et al. Depressed older patients with the atypical features of interpersonal rejection sensitivity and reversed-vegetative symptoms are similar to younger atypical patients. Am J Geriatr Psychiatry 2012; 20: 622-34.
25. Horwath E, Johnson J, Weissman MM, Hornig CD. The validity of major depression with atypical features based on a community study. J Affect Disord 1992; 26: 117-25.
26. Lasserre AM, Glaus J, Vandeleur CL, Marques-Vidal P, Vaucher J, Bastardot F, et al. Depression with atypical features and increase in obesity, body mass index, waist circumference, and fat mass: A prospective, population-based study. JAMA Psychiatry 2014; 71: 880-8.
27. Duggan CF, Lee AS, Murray RM. Do different subtypes of hospitalized depressives have different long-term outcomes? Arch Gen Psychiatry 1991; 48: 308-12.
28. Parker G, Hadzi-Pavlovic D, Brodaty H, Boyce P, Mitchell P, Wilhelm K, et al. Predicting the course of melancholic and non melancholic depression. A naturalistic comparison study. J Nerv Ment Dis 1992; 180: 693-702.
29. Melartin T, Leskela U, Rytsala H, Sokero P, Lestela-Mielonen P, Isometsa E. Co-morbidity and stability of melancholic features in DSM-IV major depressive disorder. Psychol Med 2004; 34: 1443-52.
30. Grunebaum MF, Galfalvy HC, Oquendo MA, Burke AK, Mann JJ. Melancholia and the probability and lethality of suicide attempts. Br J Psychiatry 2004; 184: 534-5.
31. Lamers F, de Jonge P, Nolen WA, Smit JH, Zitman FG, Beekman AT, et al. Identifying depressive subtypes in a large cohort study: Results from the Netherlands Study of Depression and Anxiety (NESDA). J Clin Psychiatry 2010; 71: 1582-9.
32. Lamers F, Rhebergen D, Merikangas KR, de Jonge P, Beekman AT, Penninx BW. Stability and transitions of depressive subtypes over a 2-year follow-up. Psychol Med 2012; 42: 2083-93.
33. Penninx BWJH, Beekman ATF, Smit JH, Zitman FG, Nolen WA, Spinhoven P, et al. The Netherlands Study of Depression and Anxiety (NESDA): Rationale, objectives and methods. Int J Meth Psych Res 2008; 17: 121-40.
34. World Health Organization. Composite International Diagnostic Interview, Core version 2.1: Interviewer's Manual. WHO, 1997.
35. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). APA, 1994.
36. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med 1996; 26: 477-86.
37. Lamers F, Hoogendoorn AW, Smit JH, van DR, Zitman FG, Nolen WA, et al. Sociodemographic and psychiatric determinants of attrition in the Netherlands Study of Depression and Anxiety (NESDA). Compr Psychiatry 2012; 53: 63-70.
38. Hagenaars, JA, McCutcheon, AL. Applied Latent Class Analysis. Cambridge University Press, 2002.
39. Sullivan PF, Kessler RC, Kendler KS. Latent class analysis of lifetime depressive symptoms in the national comorbidity survey. Am J Psychiatry 1998; 155: 1398-406.
40. Sullivan PF, Prescott CA, Kendler KS. The subtypes of major depression in a twin registry. J Affect Disord 2002; 68: 273-84.
41. Rodgers S, Ajdacic-Gross V, Muller M, Hengartner MP, Grosse HM, Angst J, et al. The role of sex on stability and change of depression symptom subtypes over 20 years: A latent transition analysis. Eur Arch Psychiatry Clin Neurosci 2014; 264: 577-88.
42. Lamers F, Burstein M, He JP, Avenevoli S, Angst J, Merikangas KR. Structure of major depressive disorder in adolescents and adults in the US general population. Br J Psychiatry 2012; 201: 143-50.
43. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003; 54: 573-83.
44. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988; 56: 893-7.
45. Hirschfeld RM, Williams JB, Spitzer RL, Calabrese JR, Flynn L, Keck PE Jr et al. Development and validation of a screening instrument for bipolar spectrum disorder: The Mood Disorder Questionnaire. Am J Psychiatry 2000; 157: 1873-5.
46. Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: The Scale for Suicide Ideation. J Consult Clin Psychol 1979; 47: 343-52.
47. Buist-Bouwman MA, Ormel J, De Graaf R, Vilagut G, Alonso J, Van Sonderen E, et al. Psychometric properties of the World Health Organization Disability Assessment Schedule used in the European Study of the Epidemiology of Mental Disorders. Int J Meth Psych Res 2008; 17: 185-97.
48. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-52.
49. Rush AJ, Weissenburger JE. Melancholic symptom features and DSM-IV. Am J Psychiatry 1994; 151: 489-98.
50. Keller MB, Lavori PW, Mueller TI, Endicott J, Coryell W, Hirschfeld RM, et al. Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry 1992; 49: 809-16.
51. Melartin TK, Rytsala HJ, Leskela US, Lestela-Mielonen PS, Sokero TP, Isometsa ET. Severity and comorbidity predict episode duration and recurrence of DSM-IV major depressive disorder. J Clin Psychiatry 2004; 65: 810-9.
52. Conradi HJ, de Jonge P, Ormel J. Prediction of the three-year course of recurrent depression in primary care patients: Different risk factors for different outcomes. J Affect Disord 2008; 105: 267-71.
53. Milaneschi Y, Lamers F, Mbarek H, Hottenga JJ, Boomsma DI, Penninx BW. The effect of FTO rs9939609 on major depression differs across MDD subtypes. Mol Psychiatry 2014; 19: 960-2.
54. van Loo HM, de Jonge P, Romeijn JW, Kessler RC, Schoevers RA. Data-driven subtypes of major depressive disorder: A systematic review. BMC Med 2012; 10: 156.